CHRS
Coherus BioSciences Inc
1.00$
-1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -72.8% | -14.1% | -2,026.3% | 91.9% | -87.6% | 52.8% | -339.9% | -454.8% | -400.5% | -154.7% | -470.2% | -838.6% | -478.9% | |
| 1.2% | 1.2% | 65.3% | 1.8% | 2.2% | 1.9% | 13.8% | 9.9% | 8.3% | 7.0% | 7.2% | 6.0% | 7.1% | |
| 13.3% | 11.8% | 317.1% | 11.1% | 9.7% | 11.8% | 70.7% | 52.9% | 29.3% | 84.7% | 19.4% | 34.7% | 42.3% | |
| -37.0% | 7.0% | -493.0% | 114.3% | -86.9% | 100.7% | 142.9% | -230.7% | -81.1% | -100.4% | -192.4% | -394.2% | -200.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 67.8% | 38.5% | 8,785.2% | 42.6% | 0.6% | -1.0% | -230.1% | 4,511.8% | -581.0% | -22.3% | 249.0% | 421.4% | 41.0% | |
| -0.2% | 3.6% | -32.3% | -2.6% | 0.0% | 0.0% | -3.5% | – | 0.0% | -2.1% | – | – | – | |
| – | – | – | – | -0.2% | 0.0% | – | – | 0.0% | -373.8% | – | – | – | |
| 14.9% | 0.4% | 38.4% | -289.2% | -0.2% | 0.4% | -3.5% | -2,745.5% | 0.0% | 63.4% | 435.3% | 375.6% | 226.6% | |
| 9.9% | 24.2% | 6,797.4% | -154.7% | -87.2% | 52.3% | -573.4% | 1,311.5% | -981.3% | -113.5% | 214.1% | -41.6% | -211.3% | |
| -72.8% | -14.2% | -2,026.3% | 91.9% | -87.6% | 52.8% | -339.9% | -454.8% | -400.5% | -154.7% | -470.2% | -838.6% | -478.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.